Coronavirus: WHO suspends hydoxychloroquine trial over safety

Hydroxychloroquine is most typically used to treat malaria, lupus and arthritis. The WHO had been testing the drug as part of its Solidarity trial looking at the safety and efficacy of four medications against coronavirus. But a study on Friday revealed higher mortality rates among COVID-19 patients who took the drug On Monday, the WHO announced it was suspending the hydroxychloroquine arm of its trial over safety concerns. President Donald Trump announced on Sunday that he finished taking his two-week prescription of the drug, which he had used as a prophylactic